Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C1NP
|
||||
| Former ID |
DIB019520
|
||||
| Drug Name |
compound 4g
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531910] | ||
| Formula |
C13H13NO5
|
||||
| InChI |
InChI=1S/C13H13NO5/c1-13(2)11(16)14(12(17)19-13)10(15)8-4-6-9(18-3)7-5-8/h4-7H,1-3H3
|
||||
| InChIKey |
ZYRNCIWULACSEK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Leukocyte proteinase-3 | Target Info | Inhibitor | [531910] | |
| Cathepsin G | Target Info | Inhibitor | [531910] | ||
| Leukocyte elastase | Target Info | Inhibitor | [531910] | ||
| Reactome | Common Pathway of Fibrin Clot FormationR-HSA-1474228:Degradation of the extracellular matrix | ||||
| Activation of Matrix Metalloproteinases | |||||
| Metabolism of Angiotensinogen to Angiotensins | |||||
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)R-HSA-1442490:Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.